IN2014KN02647A - - Google Patents

Info

Publication number
IN2014KN02647A
IN2014KN02647A IN2647KON2014A IN2014KN02647A IN 2014KN02647 A IN2014KN02647 A IN 2014KN02647A IN 2647KON2014 A IN2647KON2014 A IN 2647KON2014A IN 2014KN02647 A IN2014KN02647 A IN 2014KN02647A
Authority
IN
India
Prior art keywords
aptamer
target
kits
nucleic acid
detection
Prior art date
Application number
Other languages
English (en)
Inventor
Glenn Sanders
Stephan Kraemer
Evaldas Katilius
Original Assignee
Somalogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc filed Critical Somalogic Inc
Publication of IN2014KN02647A publication Critical patent/IN2014KN02647A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804Nucleic acid analysis using immunogens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811Selection methods for production or design of target specific oligonucleotides or binding molecules
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10Modifications characterised by
    • C12Q2525/205Aptamer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
IN2647KON2014 2012-06-07 2013-06-07 IN2014KN02647A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261656956P 2012-06-07 2012-06-07
PCT/US2013/044792 WO2013185078A1 (en) 2012-06-07 2013-06-07 Aptamer-based multiplexed assays

Publications (1)

Publication Number Publication Date
IN2014KN02647A true IN2014KN02647A (pt) 2015-05-08

Family

ID=49712701

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2647KON2014 IN2014KN02647A (pt) 2012-06-07 2013-06-07

Country Status (22)

Country Link
US (4) US20150141259A1 (pt)
EP (1) EP2859121B1 (pt)
JP (1) JP6298456B2 (pt)
KR (1) KR102088381B1 (pt)
CN (2) CN108614102A (pt)
AU (1) AU2013271401B2 (pt)
BR (1) BR112014030298B1 (pt)
CA (1) CA2873099C (pt)
CY (1) CY1118748T1 (pt)
ES (1) ES2617226T3 (pt)
HK (1) HK1204341A1 (pt)
HR (1) HRP20170296T1 (pt)
IL (1) IL235588B (pt)
IN (1) IN2014KN02647A (pt)
MX (1) MX356413B (pt)
MY (1) MY170164A (pt)
NZ (1) NZ701824A (pt)
PH (1) PH12014502581B1 (pt)
RU (1) RU2666989C2 (pt)
SG (2) SG10201701361WA (pt)
WO (1) WO2013185078A1 (pt)
ZA (1) ZA201408409B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110136099A1 (en) 2007-01-16 2011-06-09 Somalogic, Inc. Multiplexed Analyses of Test Samples
US7947447B2 (en) 2007-01-16 2011-05-24 Somalogic, Inc. Method for generating aptamers with improved off-rates
US8975026B2 (en) 2007-01-16 2015-03-10 Somalogic, Inc. Method for generating aptamers with improved off-rates
US20160312265A1 (en) * 2014-01-14 2016-10-27 Aptitude Medical Systems, Inc. Use of nucleic acid agents for ultra-sensitive digital detection and quantification of target molecules
JP6689758B2 (ja) * 2014-02-18 2020-04-28 ソマロジック・インコーポレーテッド 微生物検出のための組成物及び方法
CN106574925B (zh) * 2014-05-23 2019-07-26 萤火虫生物股份有限公司 用于生物测定的底物介导的反应器
GB2528643A (en) * 2014-07-08 2016-02-03 Adc Biotechnology Ltd Method of synthesising ADCs
KR102003589B1 (ko) * 2016-03-03 2019-07-24 성균관대학교산학협력단 생화학 분자 검출센서 및 다파장 형광을 이용한 생화학 분자 검출방법
CN105779609A (zh) * 2016-04-15 2016-07-20 上海伊丽萨生物科技有限公司 一种超敏免疫检测方法
CA3039057A1 (en) * 2016-10-13 2018-04-19 Laboratory Corporation Of America Holdings Devices and methods to reduce interfering compounds in biological samples
US20190317082A1 (en) * 2018-04-13 2019-10-17 Fluidigm Canada Inc. Stabilized cell acquisition for elemental analysis
WO2019246289A1 (en) * 2018-06-22 2019-12-26 Somalogic, Inc. Improved proteomic multiplex assays
US11181501B2 (en) 2018-09-11 2021-11-23 City University Of Hong Kong Method and an apparatus for determining a presence or an amount of a polyamine or its derivative in a sample
LU101073B1 (en) * 2018-12-21 2020-06-24 Luxembourg Inst Science & Tech List Dna aptamers specific of adenovirus types
KR102177672B1 (ko) * 2019-02-01 2020-11-12 주식회사 압타머사이언스 압타머를 이용한 다중(multiplex) PCR 방법
KR102113078B1 (ko) * 2019-07-05 2020-05-20 광주과학기술원 압타머의 선별 방법
CN110791551A (zh) * 2019-09-17 2020-02-14 北京化工大学 一种无载体氯霉素适配体信号放大传感器的建立方法
JP2023504683A (ja) * 2019-12-03 2023-02-06 キム・ソンチョン 試料の標的分子集団に対するプロファイルを得る方法
CN113624724A (zh) * 2020-05-07 2021-11-09 廖世奇 一种适配体分子信标对靶分子的多元检测分析方法
CN111812313B (zh) * 2020-06-22 2021-10-08 北京生物制品研究所有限责任公司 铝佐剂吸附型新型冠状病毒灭活疫苗中抗原的解离方法
EP4294920A1 (en) 2021-04-27 2023-12-27 Singular Genomics Systems, Inc. High density sequencing and multiplexed priming
WO2022265362A1 (ko) * 2021-06-14 2022-12-22 김성천 압타머를 이용하여 시료의 표적 단백질 분자 집단에 대한 프로파일을 얻는 방법

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1493825A3 (en) 1990-06-11 2005-02-09 Gilead Sciences, Inc. Method for producing nucleic acid ligands
US6242246B1 (en) 1997-12-15 2001-06-05 Somalogic, Inc. Nucleic acid ligand diagnostic Biochip
SK287932B6 (sk) * 1999-11-17 2012-05-03 Roche Diagnostics Gmbh Magnetic glass particles, method for their preparation and uses thereof
US7601497B2 (en) * 2000-06-15 2009-10-13 Qiagen Gaithersburg, Inc. Detection of nucleic acids by target-specific hybrid capture method
US7348184B2 (en) 2002-07-24 2008-03-25 Bio-Rad Laboratories, Inc. Protein interaction difference mapping
JP4806411B2 (ja) * 2004-05-19 2011-11-02 ブィピー ホールディング、エルエルシー 可視光レーザ励起ビーム及びラマン分光検出器と共に使用する光センサ、及び分析物の化学基を検出する方法
US7699979B2 (en) * 2005-01-07 2010-04-20 Board Of Trustees Of The University Of Arkansas Separation system and efficient capture of contaminants using magnetic nanoparticles
US7285835B2 (en) * 2005-02-24 2007-10-23 Freescale Semiconductor, Inc. Low power magnetoelectronic device structures utilizing enhanced permeability materials
CA2614145A1 (en) * 2005-07-05 2007-01-11 Ribomic Inc. Nucleic acid capable of binding to immunoglobulin g and use thereof
CA2634987C (en) * 2006-01-17 2017-01-03 Somalogic, Inc. Multiplexed analyses of test samples
US7855054B2 (en) * 2007-01-16 2010-12-21 Somalogic, Inc. Multiplexed analyses of test samples
US7964356B2 (en) 2007-01-16 2011-06-21 Somalogic, Inc. Method for generating aptamers with improved off-rates
US7947447B2 (en) * 2007-01-16 2011-05-24 Somalogic, Inc. Method for generating aptamers with improved off-rates
MX2010000533A (es) * 2007-07-17 2010-04-30 Somalogic Inc Analisis multiplexados de muestras de pruebas.
US8291501B2 (en) * 2008-02-08 2012-10-16 Cheng Holdings, Llc Validation of protected intra-system interconnects for digital rights management in electrical computers and digital data processing systems
EP2291168A2 (fr) * 2008-05-30 2011-03-09 L'Oréal Procedes et kits de traitement des cheveux
US8440801B2 (en) * 2008-07-14 2013-05-14 The University Of Tokyo Aptamer against IL-17 and use thereof
US9089152B2 (en) * 2009-04-13 2015-07-28 TEAGASC—Agriculture and Food Development Authority Method of producing microbeads
GB0916700D0 (en) * 2009-09-23 2009-11-04 Nanoco Technologies Ltd Semiconductor nanoparticle-based materials

Also Published As

Publication number Publication date
PH12014502581A1 (en) 2015-01-21
EP2859121B1 (en) 2016-11-30
CA2873099C (en) 2021-06-15
RU2666989C2 (ru) 2018-09-13
JP6298456B2 (ja) 2018-03-20
BR112014030298A2 (pt) 2017-06-27
RU2014152698A (ru) 2016-08-10
JP2015520385A (ja) 2015-07-16
AU2013271401B2 (en) 2018-04-05
KR102088381B1 (ko) 2020-03-13
SG11201407505XA (en) 2014-12-30
US20170176422A1 (en) 2017-06-22
ES2617226T3 (es) 2017-06-15
ES2617226T8 (es) 2019-08-27
MX2014014784A (es) 2015-03-19
CN108614102A (zh) 2018-10-02
NZ701824A (en) 2017-01-27
PH12014502581B1 (en) 2015-01-21
HRP20170296T1 (hr) 2017-04-21
MX356413B (es) 2018-05-29
CN104508150B (zh) 2021-03-12
CA2873099A1 (en) 2013-12-12
CN104508150A (zh) 2015-04-08
EP2859121A1 (en) 2015-04-15
KR20150030655A (ko) 2015-03-20
MY170164A (en) 2019-07-09
WO2013185078A1 (en) 2013-12-12
US20210239692A1 (en) 2021-08-05
AU2013271401A1 (en) 2014-11-27
HK1204341A1 (en) 2015-11-13
US20150141259A1 (en) 2015-05-21
EP2859121A4 (en) 2015-12-16
BR112014030298B1 (pt) 2022-09-27
US20180224444A1 (en) 2018-08-09
IL235588A0 (en) 2015-01-29
CY1118748T1 (el) 2017-07-12
BR112014030298A8 (pt) 2022-03-08
IL235588B (en) 2018-07-31
SG10201701361WA (en) 2017-04-27
ZA201408409B (en) 2017-08-30

Similar Documents

Publication Publication Date Title
PH12014502581A1 (en) Aptamer-based mulitiplexed assays
MX341491B (es) Analisis multiplexados de muestras de pruebas.
MX2020004617A (es) Prediccion de riesgo de evento cardiovascular y usos del mismo.
GB201200658D0 (en) Methods,compositions,and kits for determining the presence/absence of a variant nucleic acid sequence
EP3862439A3 (en) Liver cancer detection kit or device, and detection method
EP3757225A3 (en) Pancreatic cancer detection kit or device, and detection method
IN2014DN09493A (pt)
WO2012004790A3 (en) Nucleic acid aptamer-based detection methods characterized by signal enhancement
EP3654036A3 (en) Stomach cancer biomarker and detection method
MX338296B (es) Composiciones y metodos para cuantificar una secuencia de acido nucleico en una muestra.
EA030186B9 (ru) Способ проведения количественных анализов
IN2014CN03508A (pt)
WO2014186761A3 (en) Methods for determining responsiveness to an anti-cd47 agent
MX2015001961A (es) Metodos y sistemas para ensayos.
EP2254897A4 (en) METHOD, REAGENTS AND KITS FOR DETECTING NUCLEIC ACID MOLECULES
EP3216852A4 (en) Method for introducing nucleic acid, method for detecting nucleic acid, method for analyzing biological component, array device for biological component assay, and kit for analyzing biological component
GB2515944A (en) Peptide arrays
MX2015012319A (es) Sistemas de instrumento analitico.
WO2013090386A3 (en) Methods and kits for room temperature in situ detection of a target nucleic acid in a biological sample
GB2542576A (en) Method and kit of detecting the absence of micro-oranisms
WO2013166444A3 (en) Biomarker analysis using scodaphoresis
MX2015004419A (es) Deteccion de analito y determinacion de concentracion de analito mediante uso de perlas magnetizables.
EP3208333A4 (en) Method for detecting and quantifying target nucleic acid in test sample using novel positive control nucleic acid
EP4282961A3 (en) Compositions and methods for the detection and analysis of mycobacterium tuberculosis
MY182547A (en) Polymerase chain reaction detection system